Review




Structured Review

Takeda denv 2 pdk53
Denv 2 Pdk53, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/denv+2+pdk53/53+backbone+cdna+denv2+pdk/pm41702930-275-31-26
Average 86 stars, based on 1 article reviews
denv 2 pdk53 - by Bioz Stars, 2026-11
86/100 stars

Images

Related Articles

Mutagenesis:

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection
Article Snippet: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection.
Article Snippet: Competing Interests The authors declare no competing financial interest but the following competing non-financial interests: EEO has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Infection:

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection
Article Snippet: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection.
Article Snippet: Competing Interests The authors declare no competing financial interest but the following competing non-financial interests: EEO has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Transfection:

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection
Article Snippet: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection.
Article Snippet: Competing Interests The authors declare no competing financial interest but the following competing non-financial interests: EEO has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Control:

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection
Article Snippet: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection.
Article Snippet: Competing Interests The authors declare no competing financial interest but the following competing non-financial interests: EEO has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Western Blot:

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection
Article Snippet: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection.
Article Snippet: Competing Interests The authors declare no competing financial interest but the following competing non-financial interests: EEO has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Knockdown:

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection
Article Snippet: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection.
Article Snippet: Competing Interests The authors declare no competing financial interest but the following competing non-financial interests: EEO has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Microarray:

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection
Article Snippet: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection.
Article Snippet: Competing Interests The authors declare no competing financial interest but the following competing non-financial interests: EEO has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Expressing:

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection
Article Snippet: The authors declare no competing financial interest but the following competing non-financial interests: E.E.O. has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.

Article Title: Reduced dengue virus pre-membrane protein-HMGB1 interaction activates host cell transcription to attenuate infection.
Article Snippet: Competing Interests The authors declare no competing financial interest but the following competing non-financial interests: EEO has served as a dengue vaccine advisory board member for Takeda Pharmaceuticals, which has used DENV-2 PDK53 to develop TAK-003.



Similar Products

86
Takeda denv 2 pdk53
Denv 2 Pdk53, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/denv+2+pdk53/53+backbone+cdna+denv2+pdk/pm41702930-275-31-26
Average 86 stars, based on 1 article reviews
denv 2 pdk53 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results